Recent analyst upgrades from Goldman Sachs to Buy ($230 target) and Barclays to Overweight ($265 target) have propelled Palantir shares to fresh highs near $209, reflecting sustained momentum from 93% year-over-year revenue growth in Q2 2026, sharply raised full-year guidance, and accelerating U.S. commercial adoption of its AI platform. With the stock up over 60% since August amid expanding sovereign AI opportunities and high net retention, trader sentiment for the Oct 16 close shows balanced probabilities between sub-$200 and above-$218 outcomes. This pricing captures near-term volatility risks ahead of the Nov 2 earnings release, tempered by strong operating margins and free-cash-flow expansion.